Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review

Background: This study investigated the effectiveness and safety of switching from Basalin® to Lantus® in Chinese patients with diabetes mellitus (DM). Methods:  A retrospective chart review conducted using the electronic medical records of patients hospitalized at the Qingdao Endocrine and Diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xia, Zhang, Lei, Dong, Yanhu, Dong, Chao, Jiang, Jikang, Gao, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941245/
https://www.ncbi.nlm.nih.gov/pubmed/29862021
http://dx.doi.org/10.12688/f1000research.13923.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941245/
https://www.ncbi.nlm.nih.gov/pubmed/29862021
http://dx.doi.org/10.12688/f1000research.13923.1

Ejemplares similares